Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neuro-Oncology|January 18, 2025
Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targetsNathan M Kendsersky, Michal Odrobina, Nathaniel W Mabe, et al.
Nature Communications|January 20, 2024
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicityXue Zhang, Shishir M Pant, Cecily C Ritch, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2022
Epigenetic state determines inflammatory sensing in neuroblastomaAdam J Wolpaw, Liron D Grossmann, Jessica L Dessau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 29, 2025
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cellsAnna Maria Giudice, Sydney L Roth, Stephanie Matlaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung CancerAnna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Nature Communications|August 20, 2024
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastomaGuillem Pascual-Pasto, Brendan McIntyre, Margaret G Hines, et al.
Cancer Research|January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood CancersAdam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Nature Communications|August 14, 2025
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancersAlberto D Guerra, Smita Matkar, Christina Acholla, et al.
Cancer Discovery|July 31, 2024
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister CellsLiron D Grossmann, Chia-Hui Chen, Yasin Uzun, et al.
Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.
Pageof 2